
Jogo Health
JOGO: AI-driven telemedicine for chronic and neurological conditions using neuroplasticity science.
- 83
- Private company
- Bridgewater, NJ, USUnited States

JOGO: AI-driven telemedicine for chronic and neurological conditions using neuroplasticity science.
jogohealth.comCrawled Oct 15, 2026
Dr. Gordon Silverman is Professor Emeritus and Chair of Electrical and Computer Engineering at Manhattan College. Silverman and Joseph Brudny pioneered EMG biofeedback and created a fully functional unit in the 1970s.
JOGO Health is a digital neurology platform that helps patients receive comprehensive care for neurological, chronic pain, neuromuscular, neuro pelveology, and neuro gastroenterology conditions.
JOGO Health Privacy Policy and Terms of User
The New Jersey Economic Development Authority (NJEDA) invests in three businesses via its New Jersey Innovation Evergreen Fund (NJIEF). The funding supports cutting-edge ventures in the state. Details on the specific companies or investment amounts are not disclosed in the announcement.
Dec 2025NJEDANews article
JOGO Health and SohoMD collaborate to offer AI-driven EMG biofeedback migraine treatment through virtual care. The partnership integrates JOGO’s digital therapeutics with SohoMD’s telehealth platform, expanding access to neurologist-led migraine management across the U.S. Both companies specialize in neurology-focused solutions, combining AI diagnostics with clinician oversight.
Oct 2025HLTHNews article
JOGO Health partners with Mayo Clinic to research tremor types and treatment approaches. The collaboration aims to deepen medical understanding of neurological conditions through combined expertise. Both organizations leverage their respective strengths in health technology and clinical research.
Jul 2024ACCESS NewswireNews article
JOGO Health secures **$5.5 million** in a funding round led by **Hourglass Ventures**, expanding its capital base. The company, specializing in **chronic pain and neuromuscular disorder treatments**, also extends an investment opportunity for the public to align with **Mayo Clinic Ventures**. This round builds on prior backing from the Mayo Clinic’s venture arm.
Jun 2024Business WireNews article